Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications. We show 54 historical shares outstanding datapoints in our PACB shares outstanding history coverage, used to compute PACB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PACB market cap history over the course of time is important for investors
interested in comparing PACB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PACB versus a peer is one thing; comparing
PACB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PACB can fluctuate over the course of history.
With this page we aim to empower investors researching PACB by allowing them to research the PACB market cap history. |
Free PACB Email Alerts:
Video: The Importance of Market Cap
